Patents Assigned to NOVOBIND LIVESTOCK THERAPEUTICS INC.
  • Patent number: 11939371
    Abstract: Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in domestic animals or humans. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in domestic animals or humans.
    Type: Grant
    Filed: August 23, 2021
    Date of Patent: March 26, 2024
    Assignee: NOVOBIND LIVESTOCK THERAPEUTICS INC.
    Inventor: Hamlet Abnousi
  • Patent number: 11130800
    Abstract: Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in domestic animals or humans. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in domestic animals or humans.
    Type: Grant
    Filed: May 19, 2017
    Date of Patent: September 28, 2021
    Assignee: NOVOBIND LIVESTOCK THERAPEUTICS INC.
    Inventor: Hamlet Abnousi